Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Proposed Framework Services Ag'ment with Microsaic

15 Feb 2021 07:00

RNS Number : 0223P
Deepverge PLC
15 February 2021
 

15 February 2021

DeepVerge PLC

 

("DeepVerge" or "the Company")

 

DeepVerge signs Heads of Terms with Microsaic Systems plc for sales, marketing and distribution of Microsaic equipment and technology through Deepverge global distributor network

 

Proposed Framework Services Agreement to include laboratory upgrade, product development

 

DeepVerge (LSE:DVRG.L), the environmental and life science AI company, announces that it has signed a non-binding Heads of Terms with Microsaic Systems plc ("Microsaic") to enter a multi-year Framework Services Agreement ("Agreement") whereby DeepVerge will be appointed as non-exclusive agent to promote Microsaic's technologies. The Agreement, to be completed on or before the 31 March 2021, will allow for the supply of miniaturised mass spectrometry contamination detection equipment and services across DeepVerge's network of sales, marketing and distribution channels in laboratory, chemical, biochemical, biofuel and biodegradable plastic and waste-water treatment industries.

 

The Heads of Terms include provision for an initial order for two units, each worth £50,000, plus up to £150,000 commitment by DeepVerge to install pilot facilities located in the recently announced 2021 expansion of DeepVerge York, UK laboratories (RNS announcement, 10 February 2021).

 

Under the Agreement it is expected that Microsaic shall pay to DeepVerge an agency commission based on the revenues received from customers introduced by DeepVerge. The Agreement is expected to have an initial period of three years. As non executive directors of Microsaic, Gerard Brandon and Nigel Burton abstained from participating in DeepVerge's board consideration of the Heads of Terms and decision to proceed to signature of the Heads of Terms.

 

DeepVerge notes that Microsaic will also be joining the EcoWaterOS Consortium, an end-to-end water contamination detection and decontamination solutions provider network, for real-time monitoring and detection of contaminated water.

 

Gerard Brandon CEO DeepVerge plc, and ecowaterOS member commented:

 

"We are pleased to part of the commercial expansion plans of Microsaic and welcome them to the ecowaterOS consortium. The addition of the Microsaic technology to our own laboratory equipment sales portfolio is entirely complementary. This opens up additional opportunities to jointly development new products and services by working with their experts adding smart AI cloud-based data analytic technologies and best-in-class engineering which have successfully operated at commercial scale in the brewing, biofuel, chemical and wastewater treatment industries."

 

Glenn Tracey, CEO of Microsaic, commented:

"We are delighted to expand our commercial sales through a well- established network that Deepverge have within their Modern Water division. We hope to integrate our knowledge and expertise, built over 20 years on the miniaturisation of microchip-based equipment and enhance the accuracy and efficiencies of existing detection equipment of the ecowaterOS multi-continental consortium. We look forward to joining the consortium and playing our role to help mitigate the global water crisis and to bring our detection methods to new clients through the current and any future global health pandemics."

 

 

DeepVerge plc

Ross Andrews

 

+44 (0) 1904 40 4036

 

SPARK Advisory Partners

Limited

 

Neil Baldwin/Andrew Emmott

 

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / Zoe Alexander

+44 (0) 20 3621 4120

 

About DeepVerge plc (www.deepverge.com)

DeepVerge is an environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins. Utilising artificial intelligent data analytics to scientifically prove the impact of skincare product claims on skin microbiome for most of the top 20 global cosmetic company clients and remotely detect and identify in real-time, dangerous pathogens in wastewater treatment plants, drinking water, rivers, lakes and reservoirs.

 

About Microsaic (www.microsaic.com)

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Having invested £30m over the last 20 years before and after the IPO, Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection data at any step in the process workflow.

 

About EcowaterOS (www.ecowaterOS.com)

Developed by the Rinocloud division of Deepverge plc, this is a consortium of partners operating a live dynamic water management system that delivers safe clear water from rivers to wastewater treatment plants using Artificial Intelligence to provide instant alerts from remote sensors direct to stakeholders. It continuously evolves, learns and improves by bringing together multiple existing and smart technologies to create efficient water and deliver environmental protection. Over-the-air monitoring keeps stakeholders constantly up to date with web and mobile alert applications adapted for each group.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRSFWFDLEFSEEE
Date   Source Headline
1st Feb 20218:30 amRNSAppointment of former IBM Legal Counsel as CoSec
1st Feb 20217:00 amRNSAppointment of former IBM Legal Counsel as CoSec
25th Jan 20212:22 pmRNSExercise of Warrants and Total Voting Rights
18th Jan 20214:51 pmRNSExercise of Options and Total Voting Rights
15th Jan 20217:00 amRNSCompletion of Compulsory Acquisition; TVR
11th Jan 20217:00 amRNSDVRG confirms maiden Q4 profit;guides £10m in 2021
11th Dec 20207:00 amRNSNew Labskin service - update
3rd Dec 20204:26 pmRNSDirector/PDMR Shareholding
1st Dec 20207:00 amRNSTrading Update & Investor Presentation
27th Nov 20207:00 amRNSInterim analysis from Aberdeen Uni - Labskin study
25th Nov 20207:00 amRNSInvestor presentation and corporate update
23rd Nov 20209:26 amRNSHolding(s) in Company
19th Nov 20205:25 pmRNSIssue of Share Options/PDMR Dealings
18th Nov 202012:17 pmRNSTR-1: Notification of major holdings
18th Nov 202011:06 amRNSSecond Price Monitoring Extn
18th Nov 202011:00 amRNSPrice Monitoring Extension
17th Nov 20203:43 pmRNSDirector/PDMR Shareholding
17th Nov 20203:38 pmRNSAllotment of Shares Following Close of Offer
16th Nov 20207:00 amRNSUpdate on detection products
13th Nov 20205:22 pmRNSHolding(s) in Company
10th Nov 20202:57 pmRNSExercise of Warrants and Total Voting Rights
10th Nov 20201:14 pmRNSExchange and Grant of Options and Warrants
10th Nov 20207:00 amRNSAppointment of Non-Executive Director
9th Nov 20205:30 pmRNSDeepverge
9th Nov 20205:02 pmRNSAllotment of Shares and Level of Acceptances
9th Nov 20202:05 pmRNSSecond Price Monitoring Extn
9th Nov 20202:00 pmRNSPrice Monitoring Extension
9th Nov 20208:46 amRNSHolding(s) in Company
9th Nov 20208:06 amRNSOffer Unconditional in all respects
3rd Nov 20203:00 pmRNSOFFER UNCONDITIONAL AS TO ACCEPTANCES; EXTENDED
26th Oct 20206:31 pmRNSForm 8.3 - Deepverge PLC
23rd Oct 20204:41 pmRNSSecond Price Monitoring Extn
23rd Oct 20204:35 pmRNSPrice Monitoring Extension
23rd Oct 20204:08 pmRNSComment on detection of COVID-19 in UK Sewage
22nd Oct 20204:40 pmRNSSecond Price Monitoring Extn
22nd Oct 20204:35 pmRNSPrice Monitoring Extension
22nd Oct 20209:05 amRNSSecond Price Monitoring Extn
22nd Oct 20209:00 amRNSPrice Monitoring Extension
13th Oct 20203:55 pmRNSPublication of Offer Document; Rule 15 letters
13th Oct 20203:45 pmRNSReplacement - Form 8 (OPD) - Modern Water plc
9th Oct 20207:00 amRNSUpdate on Offer for Modern Water plc by DeepVerge
7th Oct 20204:40 pmRNSSecond Price Monitoring Extn
7th Oct 20204:35 pmRNSPrice Monitoring Extension
7th Oct 20202:05 pmRNSSecond Price Monitoring Extn
7th Oct 20202:00 pmRNSPrice Monitoring Extension
7th Oct 202011:05 amRNSSecond Price Monitoring Extn
7th Oct 202011:00 amRNSPrice Monitoring Extension
7th Oct 20209:05 amRNSSecond Price Monitoring Extn
7th Oct 20209:00 amRNSPrice Monitoring Extension
6th Oct 20205:21 pmRNSForm 8.3 -Deepverge PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.